Key Takeaways
- • Delaware Chancery Court denied H.I.G. Capital's motion to block a California securities fraud suit brought by two former behavioral health facility owners over a $17.5 million deal, ruling the dispute does not require Delaware litigation.
- • The court's decision allows the plaintiffs to proceed with their California-based securities fraud claims against H.I.G. Capital LLC and its affiliates without mandatory Delaware jurisdiction.
- • The ruling clarifies that contractual or corporate connections to Delaware are insufficient grounds to block out-of-state litigation when the underlying dispute centers on transactions and alleged conduct occurring in other jurisdictions.
- • This decision reduces litigation barriers for claimants challenging private equity transactions and may increase exposure for alternative asset managers facing multi-state dispute resolution.
Summary
The Delaware Chancery Court rejected H.I.G. Capital LLC's attempt to block a California securities fraud lawsuit brought by two former owners of a behavioral health facility over a $17.5 million transaction. The ruling, issued on Monday, August 10, 2026, determined that the private equity firm and its affiliates had failed to demonstrate that the dispute must be litigated in Delaware.
H.I.G. Capital had sought to consolidate the case in Delaware, presumably leveraging corporate or contractual connections to the state. However, the court found these connections insufficient to override the plaintiffs' choice of California as the litigation venue. The decision reflects a judicial determination that the substantive claims—centered on alleged securities fraud—are more appropriately adjudicated in the state where the underlying transaction occurred and where the alleged misconduct took place.
The case centers on a $17.5 million health deal between H.I.G. Capital and the two former facility owners, though the specific nature of the alleged securities fraud and transactional details remain limited in available information. The ruling permits the former owners to proceed with their claims in California courts without facing jurisdictional barriers from the defendant firm.
For alternative investment professionals and private equity stakeholders, this decision reinforces that Delaware's strong corporate law protections do not automatically extend to pre-empting state-level securities litigation. The outcome may have broader implications for how private equity firms structure disputes and evaluate multi-state legal exposure when acquiring or partnering with lower-middle-market healthcare operators. The case underscores heightened litigation risk in healthcare transactions and the limited utility of Delaware incorporation as a shield against out-of-state fraud claims.
H.I.G. Capital had sought to consolidate the case in Delaware, presumably leveraging corporate or contractual connections to the state. However, the court found these connections insufficient to override the plaintiffs' choice of California as the litigation venue. The decision reflects a judicial determination that the substantive claims—centered on alleged securities fraud—are more appropriately adjudicated in the state where the underlying transaction occurred and where the alleged misconduct took place.
The case centers on a $17.5 million health deal between H.I.G. Capital and the two former facility owners, though the specific nature of the alleged securities fraud and transactional details remain limited in available information. The ruling permits the former owners to proceed with their claims in California courts without facing jurisdictional barriers from the defendant firm.
For alternative investment professionals and private equity stakeholders, this decision reinforces that Delaware's strong corporate law protections do not automatically extend to pre-empting state-level securities litigation. The outcome may have broader implications for how private equity firms structure disputes and evaluate multi-state legal exposure when acquiring or partnering with lower-middle-market healthcare operators. The case underscores heightened litigation risk in healthcare transactions and the limited utility of Delaware incorporation as a shield against out-of-state fraud claims.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.